Cryptococcosis Market, By Treatment (Amphotericin B, Flucytosine, Fluconazole, Voriconazole, Surgery Treatment, Others), By Diagnosis (Bronchoscopy, X-ray, MRI, Lung Biopsy, CSF Polymerase Chain Reaction (PCR), CT Scan, Others), By End-Users (Clinic, Hospital, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI482421 | Publish Date: May 2024 | No. of Pages: 180

Global Cryptococcosis Market Overview

Cryptococcosis is a fungus that causes infection. Cryptococcus neoformation or Cryptococcus Gatti are the bacteria that cause it. Inhalation of fungus associated with bird species is how the sickness spreads. It has the ability to infect both animals and people. Inhaling the fungus causes humans to become infected. The fungus primarily affects the lungs, but it can also migrate to the brain, causing meningitis. Fever, headache, lethargy, dry cough, and impaired vision are all signs of the condition. Amphotericin B, flucytosine, and fluconazole can be used to treat it. The fungi Cryptococcus neoformans and Cryptococcus gattii produce cryptococcosis, which is an infectious disease. Pigeon droppings enhance the soil, hence they're mostly found there. It is disseminated by inhaling fungus, which causes a lung infection, which then spreads to the brain, resulting in meningoencephalitis. Confusion, fever, headache, blurred vision, swollen glands, weight loss, breathing difficulty, chest discomfort, weariness, neck stiffness, nausea, and vomiting are all symptoms of this condition. The Global Cryptococcosis Market accounted for US$ 4.37 billion in 2020 and is estimated to be US$ 6.74 billion by 2030 and is anticipated to register a CAGR of 5.40%.

Global Cryptococcosis Market Dynamics

Growing number of HIV patients will drive the growth of the Market

The growing number of HIV patients around the world is propelling the industry forward. Cryptococcosis has been determined to be the cause of death in 15% of HIV patients, according to reports. HIV patients are immunocompromised and have a weakened immune system, making it easy for the fungus to enter. People in developing nations are not diagnosed early due to a lack of diagnostic tests, which has an impact on the market. Several government agencies are working to eradicate the disease, and advances in detection and treatment are propelling the market.  In the projection period of 2021-2028, the cryptococcosis market will benefit from drug development, a developing clinical trial environment, and rising initiatives by the government, private organisations, and healthcare providers.

High treatment costs and a lack of clinical understanding among patients, on the other hand, will impede market expansion. In addition, in the projected period, the cryptococcosis market would be challenged by a restricted scope of testing and diagnostics due to increased mortality among cryptococcosis infected patients and a lack of experienced technicians.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Cryptococcosis Market Segmentation

Cryptococcosis Market is segmented based on treatment, diagnosis, end-user, distribution channel and region.

On the basis of Treatment, the Global Cryptococcosis Market is segmented into Amphotericin B, Flucytosine, Fluconazole, Voriconazole, Surgery Treatment, Others. Based on Diagnosis, the target market is segmented into Bronchoscopy, X-ray, MRI, Lung Biopsy, CSF Polymerase Chain Reaction (PCR), CT Scan, Others. Based on End-User, the target market is segmented into Clinics, Hospitals and Others. Based on Distribution Channel, the target market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy.

Regional Insights:

On region the Cryptococcosis Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Because of the increased frequency of cryptococcosis, technological improvements, and higher medicine costs in this area, North America is likely to hold a significant proportion of the worldwide cryptococcosis market. For instance, According to a report released by the National Institute of Health in 2019, the prevalence of cryptococcosis in the United States is estimated to be 0.4-1.3 cases per 100,000 in the general population and 2-7 cases per 100,000 in people living with AIDS, with a case fatality ratio of about 12%. As a result of the increased frequency of cryptococcosis in endemic areas, North America has a significant market share, which is supporting the total regional market expansion.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Treatment- Amphotericin B, Flucytosine, Fluconazole, Voriconazole, Surgery Treatment, Others

By Diagnosis– Bronchoscopy, X-ray, MRI, Lung Biopsy, CSF Polymerase Chain Reaction (PCR), CT Scan, Others

By End-User- Clinics, Hospitals and Others

By Distribution Channel- Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Cryptococcosis Market report based on treatment, diagnosis, end-user, distribution channel and region.

Cryptococcosis Market, By Region:

  • North America
    • Middle East & Africa
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa
    • Latin America
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Europe
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
      • U.S.
      • Canada

Global Cryptococcosis Market Key Players

The key players operating in the cryptococcosis market are Johnson & Johnson Private Limited, Bristol-Myers Squibb Company, Novartis AG, Pfizer Inc., Abbott, Glenmark Pharmaceuticals Limited, Bausch Health Companies Inc., Sigmapharm Laboratories, LLC., Astellas Pharma Inc., MATINAS BIOPHARMA HOLDINGS, INC., NuCare Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co., Ltd., Gilead Sciences, Inc., Jolly Healthcare, Bayer AG, GREENSTONE LLC, Citron Pharma, Hexal AG, Lunan Pharmaceutical Group, B.M. Pharmaceuticals, GlaxoSmithKline plc, Mylan N.V., Takeda Pharmaceutical Company Limited, and Taj Pharmaceuticals Limited, among other domestic and global players.

Global Cryptococcosis Market Company Profile

  • Johnson & Johnson Private Limited
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bristol-Myers Squibb Company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Abbott
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Glenmark Pharmaceuticals Limited
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bausch Health Companies Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bausch Health Companies Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

Global Cryptococcosis Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for cryptococcosis Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Treatment
      • Market Snippet, By Diagnosis
      • Market Snippet, By End-user
      • Market Snippet, By Distribution Channel
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation, By Treatment, 2020 – 2030, (US$ Bn)
    • Overview                                                                        
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Amphotericin B
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Flucytosine
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Fluconazole
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Voriconazole
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Surgery Treatment
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  6. Market Segmentation, By Diagnosis, 2020 – 2030, (US$ Bn)
    • Overview                                                        
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Bronchoscopy
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • X-Ray
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • MRI
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Lung Biopsy
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • CSF Polymerase Chain Reaction (PCR)
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • CT Scan
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  7. Market Segmentation, By End-User, 2020 – 2030, (US$ Bn)
    • Overview                                   
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Clinics
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Hospitals
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  8. Market Segmentation, By Distribution Channel, 2020 – 2030, (US$ Bn)
    • Overview                                                             
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospital Pharmacy
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Retail Pharmacy
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Online Pharmacy
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  9. Global Market, By Region, 2020 – 2030, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Treatment, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Diagnosis, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Treatment, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Diagnosis, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Treatment, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Diagnosis, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Treatment, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Diagnosis, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Bn), By Treatment, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Diagnosis, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  10. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  11. Company Profiles
  • Johnson & Johnson Private Limited
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bristol-Myers Squibb Company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Abbott
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Glenmark Pharmaceuticals Limited
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bausch Health Companies Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bausch Health Companies Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

The Last Word

  • Future Impact
  • About Us
  • Contact

FAQs

Global Cryptococcosis Market is segmented based on treatment, diagnosis, end-user, distribution channel and region.

Growing number of HIV patients is major factor driving the market.

During the forecast period, North America is expected to dominate the market.

The key players operating in the cryptococcosis market are Johnson & Johnson Private Limited, Bristol-Myers Squibb Company, Novartis AG, Pfizer Inc., Abbott, Glenmark Pharmaceuticals Limited, Bausch Health Companies Inc., Sigmapharm Laboratories, LLC., Astellas Pharma Inc., MATINAS BIOPHARMA HOLDINGS, INC.